Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Mason W. Freeman"'
Autor:
Elliott M. Antman, Mason W. Freeman, David E. Golan, Roger Kitterman, Erin McKenna, John Parrish, Cheryl Vaughan, Lesley Watts, Joseph Loscalzo
Publikováno v:
Journal of Clinical and Translational Science, Vol 5 (2021)
Implementation of clinically useful research discoveries in the academic environment is challenged by limited funding for early phase proof-of-concept studies and inadequate expertise in product development and commercialization. To address these lim
Externí odkaz:
https://doaj.org/article/91ea09b4e2e1478f8d55a1ec3a05c254
Autor:
Jorge F. Haller, Paul Cavallaro, Nicholas J. Hernandez, Lee Dolat, Stephanie J. Soscia, Ruth Welti, Gregory A. Grabowski, Michael L. Fitzgerald, Mason W. Freeman
Publikováno v:
Journal of Lipid Research, Vol 55, Iss 3, Pp 493-503 (2014)
ABCA12 mutations disrupt the skin barrier and cause harlequin ichthyosis. We previously showed Abca12−/− skin has increased glucosylceramide (GlcCer) and correspondingly lower amounts of ceramide (Cer). To examine why loss of ABCA12 leads to accu
Externí odkaz:
https://doaj.org/article/61096b968579476984c13ed742b53d1c
Autor:
Michael L. Fitzgerald, Ramnik Xavier, Kathleen J. Haley, Ruth Welti, Julie L. Goss, Cari E. Brown, Debbie Z. Zhuang, Susan A. Bell, Naifang Lu, Mary Mckee, Brian Seed, Mason W. Freeman
Publikováno v:
Journal of Lipid Research, Vol 48, Iss 3, Pp 621-632 (2007)
The highly branched mammalian lung relies on surfactant, a mixture of phospholipids, cholesterol, and hydrophobic proteins, to reduce intraalveolar surface tension and prevent lung collapse. Human mutations in the ABCA3 transporter have been associat
Externí odkaz:
https://doaj.org/article/ff30baedb58c4507ad5fe288a371c737
Autor:
Zhaohui Li, Yuko Kako, Ling Pang, Mason W. Freeman, Jane M. Glick, Xinzhong Wang, Ira J. Goldberg
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 12, Pp 1912-1920 (2000)
In vitro studies have shown that the binding site for microsomal triglyceride transfer protein (MTP) is within the first 17% of apoB (apoB-17). Expression of apoB-48 in McArdle cells decreases endogenous lipoprotein production; however, overexpressio
Externí odkaz:
https://doaj.org/article/7f8a7352be17456aae4ebd06b57c7a04
Autor:
Margaret E. Brousseau, Gretchen P. Eberhart, Josée Dupuis, Bela F. Asztalos, Allison L. Goldkamp, Ernst J. Schaefer, Mason W. Freeman
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 7, Pp 1125-1135 (2000)
Tangier disease (TD), caused by mutations in the ATP-binding cassette 1 (ABC-1) gene, is a rare genetic disorder characterized by severe deficiency of high density lipoproteins (HDL) in the plasma, hypercatabolism of HDL, and defective apolipoprotein
Externí odkaz:
https://doaj.org/article/953e0aab55ba427798c3141b7e7c1d65
Autor:
Margaret E. Brousseau, Ernst J. Schaefer, Josee Dupuis, Brenda Eustace, Paul Van Eerdewegh, Allison L. Goldkamp, Lisa M. Thurston, Michael G. FitzGerald, Diane Yasek-McKenna, Gilmore O'Neill, Gretchen P. Eberhart, Barbara Weiffenbach, Jose M. Ordovas, Mason W. Freeman, Robert H. Brown, Jr., Jessie Z. Gu
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 3, Pp 433-441 (2000)
Abstract: Tangier disease (TD) is an autosomal co-dominant disorder in which homozygotes have a marked deficiency of high density lipoprotein (HDL) cholesterol and, in some cases, peripheral neuropathy and premature coronary heart disease (CHD). Homo
Externí odkaz:
https://doaj.org/article/fd9cecdea07e49dd948151a1774c02e1
Publikováno v:
American Journal of Cardiovascular Drugs. 23:277-286
Autor:
Yuan‐Di Halvorsen, John Paul Lock, Juan P. Frias, Francisco José Tinahones, Dominik Dahl, Annie L. Conery, Mason W. Freeman
Publikováno v:
Diabetes, Obesity and Metabolism. 25:293-301
To compare the effects of bexagliflozin tablets 20 mg, with those of optimally titrated glimepiride when used to treat adults with type 2 diabetes mellitus (T2DM) inadequately controlled by metformin.Adults with type 2 diabetes (n = 426) taking metfo
Autor:
Mason W. Freeman, Yuan-Di Halvorsen, William Marshall, Mackenzie Pater, Jon Isaacsohn, Catherine Pearce, Brian Murphy, Nicholas Alp, Ajay Srivastava, Deepak L. Bhatt, Morris J. Brown
Publikováno v:
The New England journal of medicine.
Aldosterone synthase controls the synthesis of aldosterone and has been a pharmacologic target for the treatment of hypertension for several decades. Selective inhibition of aldosterone synthase is essential but difficult to achieve because cortisol
Publikováno v:
Journal of Hypertension. 41:e42-e43